Skip to main content
MEHA
NASDAQ Life Sciences

Functional Brands Restructures Capital with $8.7M Exchange of Preferred Stock for New Secured Notes, Convertible Preferred, and Common Shares

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
9
Price
$0.181
Mkt Cap
$3.15M
52W Low
$0.177
52W High
$8
Market data snapshot near publication time

summarizeSummary

Functional Brands Inc. announced a significant capital restructuring, exchanging existing Series A and B Preferred Stock for a package including $6.03M in new Series C Convertible Preferred Stock, $837.8K in Senior Secured Convertible Notes, $900K in cash, and 5.19M shares of common stock.


check_boxKey Events

  • Capital Restructuring

    The company exchanged $8.378 million in stated value of Series A and B Convertible Preferred Stock with investors.

  • New Securities Issued

    The exchange involved issuing $6.03 million in new Series C Convertible Preferred Stock, $837,800 in Senior Secured Convertible Notes, and 5,190,171 shares of common stock.

  • Cash Payment

    Functional Brands also paid $900,000 in cash as part of the exchange, with half paid immediately and the remainder due upon a registration statement's effectiveness or within 90 days.

  • Senior Secured Notes

    The newly issued convertible notes bear 12% interest, mature in 17 months, and are secured by a first-priority lien on substantially all of the company's assets.


auto_awesomeAnalysis

This 8-K details a comprehensive and substantial financial restructuring for Functional Brands Inc., occurring while the stock trades near its 52-week low. The company is exchanging existing preferred stock for a complex package of new securities and cash. While the transaction addresses prior preferred stock obligations, it introduces significant new elements. The issuance of Senior Secured Convertible Notes, which take a first-priority lien on company assets, elevates the risk profile for existing common equity holders. The conversion terms for the new Series C Preferred and Notes initially appear favorable, with fixed conversion prices above the current market price. However, the "Alternate Conversion Price" provision, which allows conversion at a deep discount (85% of the lowest traded price) after 24 months or an Event of Default, introduces a substantial "death spiral" risk, potentially leading to severe dilution if the stock price declines. The large volume of common stock and convertible securities being issued, relative to the company's small market capitalization, indicates a highly dilutive event. The leak-out agreement for investors selling common stock aims to manage market impact but underscores the significant overhang. Investors should closely monitor the company's financial performance and stock price stability, as the alternate conversion terms could become highly detrimental.

At the time of this filing, MEHA was trading at $0.18 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.2M. The 52-week trading range was $0.18 to $8.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed MEHA - Latest Insights

MEHA
Apr 27, 2026, 4:15 PM EDT
Filing Type: DEF 14A
Importance Score:
8
MEHA
Apr 22, 2026, 8:00 AM EDT
Source: TMX Newsfile
Importance Score:
7
MEHA
Apr 13, 2026, 4:10 PM EDT
Filing Type: PRE 14A
Importance Score:
9
MEHA
Mar 30, 2026, 10:14 AM EDT
Filing Type: 8-K
Importance Score:
9
MEHA
Mar 27, 2026, 5:08 PM EDT
Filing Type: 10-K
Importance Score:
9
MEHA
Mar 20, 2026, 8:00 AM EDT
Source: TMX Newsfile
Importance Score:
7
MEHA
Mar 13, 2026, 4:38 PM EDT
Filing Type: 8-K
Importance Score:
9
MEHA
Feb 23, 2026, 4:15 PM EST
Filing Type: 8-K
Importance Score:
8
MEHA
Feb 06, 2026, 8:12 PM EST
Filing Type: 8-K
Importance Score:
8
MEHA
Feb 04, 2026, 8:00 AM EST
Filing Type: 8-K
Importance Score:
8